Figure 2.
Changes in PD15 (g/L) in whole lung and in basal, middle and apical regions in patients treated with Prolastin versus placebo (mITT population).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.